The petition was dismissed by a Supreme Court bench headed by Justice A K Mathur. The Madhya Pradesh high court had earlier upheld a city court's decision to dismiss the state government's plea against the pharmaceutical firm. The petition filed in the apex court through counsel C D Singh stated that the High Court had failed to appreciate that the presence of foreign element in the medicine was a clear breach of provisions of the Durgs & Cosmetic Rules 1945.
A meeting of the board of directors of GlaxoSmithkline Consumer Healthcare Ltd is scheduled on January 31, 2003, inter alia, to consider and adopt the audited financial results for the year ended December 31, 2002.\n\n\n\n
GlaxoSmithkline Pharmaceuticals has posted a 52 per cent increase in net profit to Rs 35.09 crore for the first quarter ended March 31, 2003 as against Rs 23.02 crore for the corresponding quarter ended last fiscal.
Glaxo SmithKline Consumer Healthcare Ltd has posted a net profit of Rs 105.80 million for the quarter ended December 31, 2002 as compared to Rs 303.90 million in the quarter ended December 31, 2001.
Glaxo Group 'neglected the duty of making timely disclosures' to the stock exchanges the BSE and the NSE, on various occasions, the Securities and Exchange Board of India said in its order.
Companies which have been dropped from the list include Tata Motors, Hindustan Unilever, MRF, Glaxo SmithKline Consumer Healthcare, Pfizer, Dr Reddy's Labs, Glenmark Pharmaceuticals, HDFC and Kotak Mahindra Bank
Hindustan Unilever, GlaxoSmithkline Consumer Healthcare, Godrej Consumer Products, Dabur, Nestle and other FMCG companies are lining up initiatives to maximise returns from modern trade channels including hypermarkets and supermarkets.
The National Stock Exchange on Wednesday removed Satyam from its benchmark index Nifty and the IT firm will be replaced by Reliance Capital with effect from January 12.
The move is in line with the NPPA's recent policy of putting a cap on prices.
Wockhardt's US subsidiary, Wockhardt USA, has launched Ondansetron injection in the United States on December 26.
Health drinks such as Ribena, Lucozade and X-35 Body fuel may soon become the household names, as PepsiCo, Coca-Cola, Amul and GlaxoSmithkline are planning to introduce these drinks.
Tata Consultancy Services along with Bharti Televentures and National Thermal Power Corp was on Friday adjudged among the best employers in India by leading global human resources management firm Hewitt Associates.
Ranbaxy Laboratories on Monday said it has received final approval from the United States Food and Drugs Administration to manufacture and market Amoxicillin and Clavulnate Potassium tablets, a generic version of GlaxoSmithkline's Augmentin.
In a major relief to Glaxo SmithKline Pharmaceuticals Ltd, the Delhi high court on Tuesday protected its popular preparation under the brand name OSTOCALCIUM.
Take the Rediff Biz Quiz and find out how much you know about various Indian pharmaceutical companies.
One of the oldest living brands in the country, Horlicks has been innovative in its approach, which helped it survive intense competition
Increased price control over branded generic medicines has affected its profitability
The Delhi High Court on Friday stayed the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.
Tendering the shares in an open offer will lead to higher taxation.
Scholarships, sports and spirit define Phee Teik Yeoh, the new CEO of Vistara in India
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances